Suchergebnisse - "Perner, Florian"

PubPharm (49)

1

Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML

enthalten in: Blood | 2024

von Bourgeois, W. | Cutler, J. | Aubrey, B. | +22

CommentIn: Blood. 2024 Apr 11;143(15):1438-1439. - PMID 38602697

2

TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA

enthalten in: Europäisches Patentamt | 2024

von QI JUN | DAI LINGLING | PERNER FLORIAN | +1

3

Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia

enthalten in: Molecular cancer | 2023

von Tubío-Santamaría, N. | Jayavelu, A. | Schnoeder, T. | +23

4

Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia

enthalten in: Molecular cancer | 2023

von Tubío-Santamaría, N. | Jayavelu, A. | Schnoeder, T. | +23

5

MEN1 mutations mediate clinical resistance to menin inhibition

enthalten in: Nature | 2023

von Perner, F. | Stein, E. | Wenge, D. | +26

CommentIn: Nat Rev Drug Discov. 2023 May;22(5):352. - PMID 37016125

6

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

enthalten in: Nature | 2023

von Issa, G. | Aldoss, I. | DiPersio, J. | +21

CommentIn: Nat Rev Drug Discov. 2023 May;22(5):352. - PMID 37016125

7

Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia

enthalten in: Cancer discovery | 2023

von Uckelmann, H. | Haarer, E. | Takeda, R. | +11

CommentIn: Cancer Discov. 2023 Mar 1;13(3):724-745. - PMID 36455589

8

TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA

enthalten in: Europäisches Patentamt | 2023

von QI JUN | DAI LINGLING | PERNER FLORIAN | +1

9

TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA

enthalten in: Europäisches Patentamt | 2023

von QI JUN | DAI LINGLING | PERNER FLORIAN | +1

10

A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition

enthalten in: bioRxiv.org | 2023

von Soto-Feliciano, Y. | Sánchez-Rivera, F. | Perner, F. | +19

1
2
3
4
5
Nächster »
[5]